A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy

SIMPLE SUMMARY: Canine hemangiosarcoma shares many clinical, histologic and molecular features with human angiosarcoma. Thus, the dog represents a powerful and alternative model of spontaneously occurring hemangiosarcoma for comparative studies and developmental therapeutic investigation. In both sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconato, Laura, Tiraboschi, Luca, Aralla, Marina, Sabattini, Silvia, Melacarne, Alessia, Agnoli, Chiara, Balboni, Andrea, Salvi, Marta, Foglia, Armando, Punzi, Sofia, Romagnoli, Noemi, Rescigno, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486958/
https://www.ncbi.nlm.nih.gov/pubmed/37686485
http://dx.doi.org/10.3390/cancers15174209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486958/
https://www.ncbi.nlm.nih.gov/pubmed/37686485
http://dx.doi.org/10.3390/cancers15174209

Ejemplares similares